|
Primary Care Annual Author
Index 2001
[ Subject
| Author ]
[ A | B
| C | D | E |
F | G | H | I
| J | K | L |
M | N | O | P
| Q | R | S | T
| U | V | W |
X | Y | Z ]
A
Abelson AG
Preservation of bone density in postmenopausal women. Dec(suppl):20—24
Women at risk. Jul(suppl):4—9
Arias R
A call for clarity in breast care. Oct:8—11
back to top
B
Bachmann G
Vaginal atrophy. Nov(suppl):19—22
Vulvovaginal candidiasis: effects on women's health care. March(suppl):6—7
Baldor R
Melanoma. Jun:42—46
Baum EB
Outpatient physical therapy. Jun(suppl):26—31
Bremer CC
Endometrial biopsy. Mar:47—51
Brotzman GL, see Butler DJ
Brown CS
Psychotropic medications, part 1: use during pregnancy. Jul:27—32
Brown HP
Clinician—patient communication. Nov(suppl):8—10
Emergency contraceptive pills. Mar:17—24
Burkman RT
Reflections. Aug:8
Butler DJ
Bioterrorism and anthrax anxiety. Dec:8—9
back to top
C
Calhoun AH, see Mannix LK
Cefalu C
Confusional states in older women. Jun(suppl):16—25
Chesnut CH III
Pharmacotherapeutic options. Jul(suppl):10—14
Choi MW
Menopause and mood. Aug:49—50
Cohen HD
Obesity and metabolic changes in aging women. Jun(suppl):39—43
back to top
D
Datlow M, see Diesfeld PW
Davidson MH
Cardiovascular implications of hormonal therapy. Dec(suppl):13—19
Davis G
Female circumcision. Aug:23—32
Davtyan CA
Mifepristone. Jul:37—42
Dayspring TD
Coronary artery disease prevention in women. Jan:47—53
Dickerson VM
Access to emergency contraception in the United States. Sep:8—13
Contraception in the perimenopause. Jun:33—40
Dickler MN
Prophylactic effects shown: SERMs can -prevent breast cancer. Jan:16—28
Diesfeld PW
More than a love bite. Nov:47
back to top
E
Ellis J, see Davis G
Eskew PN
Deciphering the codes. Jan:37
Eskin BA
Common benign conditions of the breast. Oct:35—40
back to top
F
Faro S
Treating vulvovaginal candidiasis. March(suppl):26—31
Fiore T
Exercise during pregnancy. Apr:26—30
Foreyt JP, see Volding DC
Freedman M
Enhancing normal sexual function. Nov(suppl):15—18
Freeman R
Hot flashes: prescription alternatives to ERT/HRT. Apr:61—62
back to top
G
Gelfand MM
Estrogen—androgen therapy. Sep:45—46
Giesser B, see also Holland N
Multiple sclerosis, part 1: prompt diagnosis and early intervention.
Nov:36—40
Gilliam ML
ERT/HRT use in African-American women, part 1: implications for
osteoporosis. May:34—39
Goldberg J
Private or public: umbilical cord blood should be preserved and
stored. Apr:42—53
Goldstein PJ, see Koklanaris N
Gorodeski GI
ERT/HRT in diabetic women. Jan:33—34
Graham V, see Koklanaris N
Greiger-Zanlungo P
HIV and women. Mar:38—45
back to top
H
Heber D
Fat metabolism throughout the life cycle. Apr:16—25
Henzl MR, see Faro S
Hill M, see Brown CS
Holland N, see also Giesser B
Multiple sclerosis, part 2: symptom management. Dec:15—22
Hudson T
Managing perimenopausal symptoms: an -integrative medicine approach.
Aug:13—20
Natural progesterone. Apr:32—41
Soy and women's health. Dec:24—28
back to top
I
Irrgang JJ, see Baum EB
back to top
J
Johnson KC
Hormone replacement and cardiovascular -disease. Oct(suppl):5—9
back to top
K
Kakuni AM, see Volding DC
Kaunitz AM
Reduced-dose oral contraceptives. Sep:24—32
Keith LG
Breast cancer. Oct:15—26
Kingsberg S
Menopause and sexual functioning. Jun:51—52
Knutson C, see Brown HP
Koklanaris N
Antenatal corticosteroids. May:27—33
Kowey PR
The role of potassium. Oct(suppl):10—13
Krivak TC
Tubo-ovarian abscess. Jun:18—30
Kronenberg F
Hot flashes: nonprescription alternatives to ERT/HRT. Mar:54—55
Krueger M, see Davis G
Krychman M
Sexual dysfunction: current issues. Nov(suppl):4—7
back to top
L
Laguens M, see Keith LG
Levinson RS
Vulvovaginal candidiasis: bioadhesive technology. March(suppl):21—23
Lobo RA
Progestogens: new approaches. Oct(suppl):19—22
Recent findings in cardiovascular disease. Oct(suppl):3—4
Lyon DS
Borderline personality disorder. Jul:22—26
back to top
M
Maidman J
Seizure prophylaxis: magnesium sulfate advised in pre-eclamptic
parturients. Aug:34—39
Mannix LK
Menstrual migraine. Sep:35—40
Mariani EP, see Faro S
Martens M
Vulvovaginal candidiasis: a consensus summary. March(suppl):24—25
Mayeaux EJ Jr
Work-up of bacterial vaginosis. Mar:25—30
McFee RB
Chest pain in female adolescents. Feb:14—30
McNamara DE
Medical concerns of endurance athletes. Jul:14—20
Mirabello J
"Occult" hysterectomy. Feb:62
Mirhashemi R
Hereditary gynecologic malignancies. Feb:38—51
Mitchell ES, see Woods NF
Monif G
Vulvovaginal candidiasis: diagnostic issues. March(suppl):10—11
back to top
N
Nachtigall LE
Colorectal cancer: does estrogen play a protective role— Nov:45—46
Nieves-Neira W, see Mirhashemi R
Nolan TE
Civility—it's to our advantage. Apr:10—12
Coding and compliance can't be ignored. Jan:8—13
Novielli KD
Meeting caregivers' health care needs. Jun(suppl):32—38
Meeting the needs of the aging female patient. Jun(suppl):9
back to top
O
O'Boyle A, see Davis G
Oleszczuk AK, see Keith LG
Oleszczuk JJ, see Keith LG
back to top
P
Parks SM, see Novielli KD
Pector EA
Bereavement in multiple birth, part 1: general considerations. Nov:31—35
Phillips OP
Infertility, part 1: genetic causes in females. Aug:40—44
Infertility, part 2: genetic causes in males. Oct:31—34
Pinkerton JAV
Postmenopausal osteoporosis: pharmacologic options for prevention.
Jul:47—48
Pitt B
Aldosterone-receptor blocking agents. Oct(suppl):14—18
Pope CS
Urinary incontinence: evaluation and nonsurgical management. Jan:54—60
Portman DJ
Hormone replacement therapy. Dec(suppl):25—29
Propst A, see Krivak TC
Purvis JM
Chronic noncancer pain. Dec:29—34
Putterman C
Risk factors for osteoporosis. Jul(suppl):2—3
back to top
R
Rabin J, see Pope CS
Reever MM, see Lyon DS
Richwald GA
External genital warts. Nov:17—24
Robbins MR
Equity in contraceptive prescription coverage. Jun:10—15
Robinson J
A contrary view: routine magnesium sulfate prophylaxis is unnecessary.
Aug:35—39
Rothert M
Counseling for continuance: improving use of ERT/HRT. Dec:40—41
back to top
S
Sand PK
Overactive bladder in women. Jun(suppl):10—15
Sepilian V, see Eskin BA
Shulman LP, see also Faro S, Krychman
M
Evidence-based medicine, revisited. Nov:9
New medicine, same old problems. Feb:8
Sexuality: the evaluation and care of women. Nov(suppl):3
Vulvovaginal candidiasis: safety and drug interactions. March(suppl):19—20
Sidani M
Thyroid disorders in the elderly. Feb:52—57
Simon JA
Surgically induced menopause. Feb:35—36
Skaer TL, see Richwald GA
Skerrett D
Public UCB banks. Apr:42—53
Smith-Levitin M, see Pector EA
Sobel J
Candida pathogens and antifungal susceptibility. March(suppl):12—14
Speroff L
Hormone replacement and breast cancer. Dec(suppl):6—12
Starz TW, see Baum EB
Strachan DD
Evaluation of hair loss in women. Apr:54—58
back to top
T
Taylor RB
Menopause and the generalist physician. Jul:10—11
Thorneycroft IH
Drospirenone. Nov:26—30
Trope L
The business of medicine. Mar:8
back to top
U
Unger J
Diabetes management in the new millennium. May:10—11
Pre-conception management of women with type I diabetes. May:40—46
back to top
V
Vahdat L
Contrary point of view: data regarding SERMs are inconclusive. Jan:17—26
Volding DC
Reducing CVD risk through lifestyle modification. Jun(suppl):44—48
back to top
W
Walsleben JA
Sleep disorders in aging women. May:16—24
Woods NF
Menopause transition. Oct:45—46
Woodward S
Sleep and menopause. May:51—52
back to top
Y
Yeo SA, see Fiore T
back to top
Z
Zieman M
Transdermal contraception. Dec:13—14
back to top
|
